NOVONESIS (NOVOZYMES) B

Novonesis B Rockets to Danish Elite Index Lead with U.S. Expansion & Solid Growth

Novonesis B surges in the Danish elite index, driven by US manufacturing expansion, organic sales growth, and a strong balance sheet, signaling robust future prospects.

NOVONESIS (NOVOZYMES) B
Denmark
Health Care
Materials
AI generated

Vanessa Liu

23/10/2026, 12:20

3 minutes to read

Novonesis B Surges 1.54% in March, Reaching DKK 463 per Share

Novonesis B climbs 1.54% as its 52‑week high nears, driven by biopharma demand; see market cap, volume and 24‑h performance vs peers.

NOVONESIS (NOVOZYMES) B
Denmark
Health Care
Materials
AI generated

Elliot Mercer

21/10/2026, 01:28

2 minutes to read